Market open

Bioventus/BVS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Bioventus

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Ticker

BVS
Trading on

Industry

Health Care Equipment & Supplies

Employees

1,030

Bioventus Metrics

BasicAdvanced
$733M
Market cap
-
P/E ratio
-$0.66
EPS
0.84
Beta
-
Dividend rate
$733M
0.84
$11.63
$2.85
503K
1.334
0.731
192.088
214.512
0.70%
2.18%
-25.82%
1.327
4.86
-2.61
92.134
5.14%
-85.47%
12.60%
36.62%

What the Analysts think about Bioventus

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Bioventus stock.

Bioventus Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Bioventus Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy BVS

$

Sign up or log in to buy
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bioventus stock?

Bioventus (BVS) has a market cap of $733M as of October 11, 2024.

What is the P/E ratio for Bioventus stock?

The price to earnings (P/E) ratio for Bioventus (BVS) stock is 0 as of October 11, 2024.

Does Bioventus stock pay dividends?

No, Bioventus (BVS) stock does not pay dividends to its shareholders as of October 11, 2024.

When is the next Bioventus dividend payment date?

Bioventus (BVS) stock does not pay dividends to its shareholders.

What is the beta indicator for Bioventus?

Bioventus (BVS) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.